Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for Cellectar Biosciences, Inc. in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
CP
Caligan Partners LP
|
470.0K | 2.69% | NEW | Q2 '26 | 0.1% | |
|
Shares held by quarter
Peak holding470.0K (Q2'26)
Change over 8 quarters+470.0K
Share of the company2.690%
|
||||||
|
SC
Stempoint Capital LP
|
354.9K | 2.03% | NEW | Q2 '26 | 0.2% | |
|
Shares held by quarter
Peak holding354.9K (Q2'26)
Change over 8 quarters+354.9K
Share of the company2.030%
|
||||||
27 more super investors behind a free account
See every manager holding Cellectar Biosciences, Inc., how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VT
Vanguard Index Funds
|
$512K | 184.1K | 1.05% | 0.00% | June 30, 2026 |
|
VE
Vanguard Index Funds
|
$398K | 143.2K | 0.82% | 0.00% | June 30, 2026 |
5 more funds behind a free account
See every fund holding Cellectar Biosciences, Inc. and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
LJ
Longcor Jarrod
Insider
|
20.5K | 0.12% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company0.120%
|
||||||
|
CJ
Caruso James V
Insider
|
20.3K | 0.12% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company0.120%
|
||||||
2 more holders behind a free account
See every insider and 5%+ holder of Cellectar Biosciences, Inc..
Sign up freeLoading...